Back to News
Market Impact: 0.1
Telix Appoints David Gill as Chair
Source: globenewswire.com
Management & Governance
Telix Pharmaceuticals appointed David Gill as Chair of the Board, effective immediately. The announcement is corporate governance-focused with no disclosed financial guidance, operating update, or new deal impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
TLX0.25
More News
- Supermicro promised a new CFO in December 2024. A $2.5 billion smuggling case and a co-founder’s arrest later, it has one
- Anduril CEO defends Trump administration contracts: 'We've done incredibly well under Biden'
- Anthropic taps nonprofits METR and SecureBio to help assess risks and safety practices
- Bank of America had to bring in 1,000 contractors to patch all the bugs Mythos identified
- Rosenblatt reiterates Buy on Super Micro stock after CFO hire
- Why is Caterpillar stock sliding today?